Comments on: Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial https://russian.lifeboat.com/blog/2021/09/efficacy-and-safety-of-baricitinib-for-the-treatment-of-hospitalised-adults-with-covid-19-cov-barrier-a-randomised-double-blind-parallel-group-placebo-controlled-phase-3-trial Safeguarding Humanity Thu, 02 Sep 2021 02:22:22 +0000 hourly 1 https://wordpress.org/?v=6.0.2